BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Vyas D, L’Esperance HE, Vyas A. Stool therapy may become a preferred treatment of recurrent Clostridium difficileWorld J Gastroenterol 2013; 19(29): 4635-4637 [PMID: 23922461 DOI: 10.3748/wjg.v19.i29.4635]
URL: https://www.wjgnet.com/1007-9327/full/v19/i29/4635.htm
Number Citing Articles
Heather K. Allen, Julian Trachsel, Torey Looft, Thomas A. Casey. Finding alternatives to antibioticsAnnals of the New York Academy of Sciences 2014; 1323(1): 91 doi: 10.1111/nyas.12468
Paul J Kennedy, John F Cryan, Timothy G Dinan, Gerard Clarke. Irritable bowel syndrome: A microbiome-gut-brain axis disorder?World Journal of Gastroenterology 2014; 20(39): 14105-14125 doi: 10.3748/wjg.v20.i39.14105
Ardeshir Rineh, Michael J Kelso, Fatma Vatansever, George P Tegos, Michael R Hamblin. Clostridium difficileinfection: molecular pathogenesis and novel therapeuticsExpert Review of Anti-infective Therapy 2014; 12(1): 131 doi: 10.1586/14787210.2014.866515
Guglielmo Borgia, Alberto Enrico Maraolo, Maria Foggia, Antonio Riccardo Buonomo, Ivan Gentile. Fecal microbiota transplantation forClostridium difficileinfection: back to the futureExpert Opinion on Biological Therapy 2015; 15(7): 1001 doi: 10.1517/14712598.2015.1045872
Dinesh Vyas, Apoorva Aekka, Arpita Vyas. Fecal transplant policy and legislationWorld Journal of Gastroenterology 2015; 21(1): 6-11 doi: 10.3748/wjg.v21.i1.6